Can a common gout pill protect heart bypass patients?
NCT ID NCT07287345
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing whether the anti-inflammatory drug colchicine can lower inflammation and reduce the risk of atrial fibrillation (an irregular heartbeat) after coronary artery bypass surgery. 24 adults scheduled for bypass surgery will be randomly assigned to receive either colchicine or a placebo, starting 5 days before surgery and continuing for 10 days after. Researchers will measure inflammatory markers and track who develops atrial fibrillation, aiming to gather data for a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- colchicine
- What this could lead to
- If it works, this could point toward a simple, low-cost way to prevent a common complication of heart bypass surgery.
- What could go wrong
- This is a very small pilot study with only 24 participants, so results may not apply to everyone. Colchicine can cause side effects like stomach upset or, rarely, more serious issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLCHICINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kentucy
RECRUITINGLexington, Kentucky, 40536, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan replace invasive heart imaging before bypass surgery?
- Epilepsy drug may protect organs during heart surgery — trial tests the idea
- A simple eye mask might protect sleep and calm confusion after heart surgery
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program